Please login to the form below
ViroPharma
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ViroPharma's 2013 immunology sales performance.
Nabriva Therapeutics appoints chief medical officer
Her career has seen her hold positions at Shire, ViroPharma, Pfizer, GlaxoSmithKline and Merck &Co.
Merck says drug for CMV in transplant patients hits targets
phase III testing that it acquired along with ViroPharma in 2013.
FDA grants fast track designation to Shire’s Cinryze
At the end of 2013, Shire signed a deal with US company Viropharma for around $4.2bn which gave the company rights to Cinryze.
Pharma deals in August 2015
indication]. Interestingly, the right to make the Meritage acquisition came via the purchase of ViroPharma.
Medius Deal Watch table for February 2015
Turkey. † US. †† Financial details source - Viropharma's 2013 Consolidated Financial Statement. .
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Medical Writer/ Senior Medical Writer opportunities – Macclesfie...
-
competitive salary and benefits package
-
Senior Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- Rising demand and understaffing puts NHS waiting times up again
- Lucid demonstrates continual investment in its central services with the appointment of its new Head of Talent, Resourcing and HR projects
- Bluebird puts €1.57m price on gene therapy Zynteglo
- Q&A with Raman Sehgal
- Hansoh Pharma shares head skyward after HKEX debut
- GSK joins forces with Doudna’s CRISPR lab
PMHub
M3 (EU)
M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...
Latest intelligence
- What are you doing, Dave?
- Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
- Fake News is Bad for your Health
- Ill informed patients make poor health decisions...
- Secrets of Pharma Advertising
- If the goal of branding is to be different, why do so many Pharma brand ads look the same?...
Quick links
Infographics
